The Latest Breaking News from CVS Caremark

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO and cofounder Jordan Feldman says there’s an opportunity for disruption.

After a large walkout forced at least a dozen stores to shut down in the Kansas City area, CVS promises change. But critics say the crisis in staffing and unfair pay extends beyond that market.

These outperformers are all trading under $10 per share - for now. After beating the S&P 500 year-to-date, analysts think these standout single-digit stocks all have room to keep running higher.

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

Express Scripts, the pharmacy benefit manager that Cigna Corp. bought in 2018, is being investigated by the Federal Trade Commission for what regulators claim is influence over drug prices wielded by pharmacy benefit managers and transparent business practices.